Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

BACKGROUND: Aberrant DNA methylation may offer opportunities in revolutionizing cancer screening and diagnosis. We sought to identify a non-invasive DNA methylation-based screening approach using cell-free DNA (cfDNA) for early detection of hepatocellular carcinoma (HCC). METHODS: Differentially, DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Biyuan, Ma, Fang, Liu, Hao, Hu, Jixiong, Rao, Le, Liu, Chun, Jiang, Yongfang, Kuangzeng, Shuyu, Lin, Xuan, Wang, Chenyang, Lei, Yiyu, Si, Zhongzhou, Chen, Guangshun, Zhou, Ning, Liang, Chengbai, Jiang, Fangqing, Liu, Fenge, Dai, Weidong, Liu, Wei, Gao, Yawen, Li, Zhihong, Li, Xi, Zhou, Guangyu, Li, Bingsi, Zhang, Zhihong, Nian, Weiqi, Luo, Lihua, Liu, Xianling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759185/
https://www.ncbi.nlm.nih.gov/pubmed/35027051
http://dx.doi.org/10.1186/s12916-021-02201-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759185/
https://www.ncbi.nlm.nih.gov/pubmed/35027051
http://dx.doi.org/10.1186/s12916-021-02201-3

Ejemplares similares